SI-BONE, Inc. Common Stock (SIBN) is a publicly traded Healthcare sector company. As of May 21, 2026, SIBN trades at $14.75 with a market cap of $654.60M and a P/E ratio of -19.64. SIBN moved -0.13% today. Year to date, SIBN is -25.79%; over the trailing twelve months it is -24.81%. Its 52-week range spans $11.48 to $21.89. Analyst consensus is strong buy with an average price target of $22.17. Rallies surfaces SIBN's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
SIBN financials on Rallies include revenue, net income, EPS, valuation metrics, market cap, price history, and balance sheet context. SIBN recently traded at $14.75. Market cap is $654.60M. P/E ratio is -19.64. Revenue is $167.18M.
| Metric | Value |
|---|---|
| Price | $14.75 |
| Market Cap | $654.60M |
| P/E Ratio | -19.64 |
| EPS | $-0.75 |
| Dividend Yield | 0.00% |
| 52-Week High | $21.89 |
| 52-Week Low | $11.48 |
| Volume | 26 |
| Avg Volume | 0 |
| Revenue (TTM) | $167.18M |
| Net Income | $-30.91M |
| Gross Margin | 79.03% |
| Year | Revenue | Net Income | EPS |
|---|---|---|---|
| 2024 | $167.18M | $-30.91M | $-0.75 |
| 2023 | $138.89M | $-43.34M | $-1.13 |
| 2022 | $106.41M | $-61.26M | $-1.79 |
| 2021 | $90.15M | $-56.57M | $-1.71 |
7 analysts cover SIBN: 0 strong buy, 7 buy, 0 hold, 0 sell, 0 strong sell. Consensus rating is strong buy. Average price target: $22.17.